Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-9-5p
|
MIMAT0000441 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_1748214 | 2.18 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr21_-_44846999 | 1.99 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr4_+_111397216 | 1.91 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr11_+_69924397 | 1.87 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr21_-_28338732 | 1.85 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr17_-_1395954 | 1.83 |
ENST00000359786.5
|
MYO1C
|
myosin IC |
chr7_-_27224795 | 1.82 |
ENST00000006015.3
|
HOXA11
|
homeobox A11 |
chr17_+_12569306 | 1.79 |
ENST00000425538.1
|
MYOCD
|
myocardin |
chr7_-_45960850 | 1.78 |
ENST00000381083.4
ENST00000381086.5 ENST00000275521.6 |
IGFBP3
|
insulin-like growth factor binding protein 3 |
chr3_+_30648066 | 1.75 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr1_+_199996702 | 1.68 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr2_+_121103706 | 1.63 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
chr13_+_110959598 | 1.55 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr10_-_33623564 | 1.55 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
chr6_-_82462425 | 1.53 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr1_-_48462566 | 1.53 |
ENST00000606738.2
|
TRABD2B
|
TraB domain containing 2B |
chr11_+_14665263 | 1.53 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
chr3_+_154797428 | 1.49 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
chr8_+_22224811 | 1.43 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr2_+_85981008 | 1.40 |
ENST00000306279.3
|
ATOH8
|
atonal homolog 8 (Drosophila) |
chr19_-_46272106 | 1.39 |
ENST00000560168.1
|
SIX5
|
SIX homeobox 5 |
chr14_-_23451845 | 1.38 |
ENST00000262713.2
|
AJUBA
|
ajuba LIM protein |
chr21_+_46825032 | 1.37 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
chr5_+_40909354 | 1.36 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr13_+_93879085 | 1.35 |
ENST00000377047.4
|
GPC6
|
glypican 6 |
chr1_-_154943212 | 1.31 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr1_+_117452669 | 1.31 |
ENST00000393203.2
|
PTGFRN
|
prostaglandin F2 receptor inhibitor |
chr2_-_218808771 | 1.22 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
chr4_+_77356248 | 1.22 |
ENST00000296043.6
|
SHROOM3
|
shroom family member 3 |
chr2_-_208030647 | 1.22 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr12_-_102874416 | 1.19 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr17_+_4675175 | 1.18 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
chr2_-_161350305 | 1.18 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr12_+_56521840 | 1.16 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr17_+_14204389 | 1.16 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
chr1_+_116184566 | 1.15 |
ENST00000355485.2
ENST00000369510.4 |
VANGL1
|
VANGL planar cell polarity protein 1 |
chr11_-_68609377 | 1.14 |
ENST00000265641.5
ENST00000376618.2 |
CPT1A
|
carnitine palmitoyltransferase 1A (liver) |
chr4_-_157892498 | 1.13 |
ENST00000502773.1
|
PDGFC
|
platelet derived growth factor C |
chr1_+_100111479 | 1.10 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
chr3_-_185542817 | 1.09 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_-_48937982 | 1.08 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
chr11_-_10590238 | 1.08 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr2_+_46524537 | 1.08 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr1_-_6321035 | 1.07 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr12_+_20522179 | 1.07 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr17_-_41174424 | 1.07 |
ENST00000355653.3
|
VAT1
|
vesicle amine transport 1 |
chr1_+_65613217 | 1.06 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
chr3_+_193853927 | 1.06 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr6_-_138893661 | 1.05 |
ENST00000427025.2
|
NHSL1
|
NHS-like 1 |
chr9_-_16870704 | 1.05 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr5_-_180242534 | 1.04 |
ENST00000333055.3
ENST00000513431.1 |
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chrX_+_49687216 | 1.03 |
ENST00000376088.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr7_+_127881325 | 1.02 |
ENST00000308868.4
|
LEP
|
leptin |
chr5_+_135364584 | 1.02 |
ENST00000442011.2
ENST00000305126.8 |
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr15_-_72612470 | 1.01 |
ENST00000287202.5
|
CELF6
|
CUGBP, Elav-like family member 6 |
chr2_+_232573208 | 1.00 |
ENST00000409115.3
|
PTMA
|
prothymosin, alpha |
chr12_+_3186521 | 0.99 |
ENST00000537971.1
ENST00000011898.5 |
TSPAN9
|
tetraspanin 9 |
chr3_-_46037299 | 0.99 |
ENST00000296137.2
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
chr3_-_120170052 | 0.98 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr15_-_50978965 | 0.97 |
ENST00000560955.1
ENST00000313478.7 |
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7 |
chr9_+_116917807 | 0.97 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr2_-_20424844 | 0.97 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr6_-_169654139 | 0.96 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
chr17_-_42908155 | 0.96 |
ENST00000426548.1
ENST00000590758.1 ENST00000591424.1 |
GJC1
|
gap junction protein, gamma 1, 45kDa |
chr7_+_115850547 | 0.96 |
ENST00000358204.4
ENST00000455989.1 ENST00000537767.1 |
TES
|
testis derived transcript (3 LIM domains) |
chr1_+_155108294 | 0.95 |
ENST00000303343.8
ENST00000368404.4 ENST00000368401.5 |
SLC50A1
|
solute carrier family 50 (sugar efflux transporter), member 1 |
chr3_+_29322803 | 0.95 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr8_-_119124045 | 0.94 |
ENST00000378204.2
|
EXT1
|
exostosin glycosyltransferase 1 |
chr17_+_1958388 | 0.93 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr5_-_149535421 | 0.93 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr11_-_9113137 | 0.92 |
ENST00000520467.1
ENST00000309263.3 ENST00000457346.2 |
SCUBE2
|
signal peptide, CUB domain, EGF-like 2 |
chr9_+_101705893 | 0.92 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr7_-_132261253 | 0.92 |
ENST00000321063.4
|
PLXNA4
|
plexin A4 |
chr3_+_36421826 | 0.92 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr11_+_60681346 | 0.90 |
ENST00000227525.3
|
TMEM109
|
transmembrane protein 109 |
chr3_-_32544900 | 0.89 |
ENST00000205636.3
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6 |
chr7_-_95225768 | 0.89 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
chr19_-_460996 | 0.88 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chr15_-_42264702 | 0.88 |
ENST00000220325.4
|
EHD4
|
EH-domain containing 4 |
chr16_+_58059470 | 0.87 |
ENST00000219271.3
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted) |
chr18_+_55102917 | 0.87 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
chr16_+_68771128 | 0.86 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr3_-_98620500 | 0.85 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr14_+_52118576 | 0.85 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
chr17_-_18266797 | 0.84 |
ENST00000316694.3
ENST00000539052.1 |
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
chr3_+_111578027 | 0.84 |
ENST00000431670.2
ENST00000412622.1 |
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chr19_-_15560730 | 0.83 |
ENST00000389282.4
ENST00000263381.7 |
WIZ
|
widely interspaced zinc finger motifs |
chr9_-_117880477 | 0.83 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr13_+_96329381 | 0.82 |
ENST00000602402.1
ENST00000376795.6 |
DNAJC3
|
DnaJ (Hsp40) homolog, subfamily C, member 3 |
chr10_+_101419187 | 0.82 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
chr10_+_60272814 | 0.81 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr3_-_123168551 | 0.81 |
ENST00000462833.1
|
ADCY5
|
adenylate cyclase 5 |
chr5_-_158526756 | 0.81 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
chr1_-_156051789 | 0.80 |
ENST00000532414.2
|
MEX3A
|
mex-3 RNA binding family member A |
chr3_+_187930719 | 0.80 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr14_-_90085458 | 0.80 |
ENST00000345097.4
ENST00000555855.1 ENST00000555353.1 |
FOXN3
|
forkhead box N3 |
chr5_+_122424816 | 0.80 |
ENST00000407847.4
|
PRDM6
|
PR domain containing 6 |
chr6_+_136172820 | 0.79 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr4_-_142053952 | 0.78 |
ENST00000515673.2
|
RNF150
|
ring finger protein 150 |
chr2_-_136873735 | 0.77 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr19_+_1941117 | 0.76 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr9_+_116638562 | 0.76 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
chr3_+_31574189 | 0.76 |
ENST00000295770.2
|
STT3B
|
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
chr5_+_34656331 | 0.75 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
chr12_+_56511943 | 0.74 |
ENST00000257940.2
ENST00000552345.1 ENST00000551880.1 ENST00000546903.1 ENST00000551790.1 |
ZC3H10
ESYT1
|
zinc finger CCCH-type containing 10 extended synaptotagmin-like protein 1 |
chr15_+_91411810 | 0.74 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr10_-_62704005 | 0.73 |
ENST00000337910.5
|
RHOBTB1
|
Rho-related BTB domain containing 1 |
chr1_-_204329013 | 0.73 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chr3_+_61547585 | 0.72 |
ENST00000295874.10
ENST00000474889.1 |
PTPRG
|
protein tyrosine phosphatase, receptor type, G |
chr17_+_36886478 | 0.71 |
ENST00000439660.2
|
CISD3
|
CDGSH iron sulfur domain 3 |
chr5_+_162864575 | 0.71 |
ENST00000512163.1
ENST00000393929.1 ENST00000340828.2 ENST00000511683.2 ENST00000510097.1 ENST00000511490.2 ENST00000510664.1 |
CCNG1
|
cyclin G1 |
chr9_+_12775011 | 0.71 |
ENST00000319264.3
|
LURAP1L
|
leucine rich adaptor protein 1-like |
chr5_-_44388899 | 0.70 |
ENST00000264664.4
|
FGF10
|
fibroblast growth factor 10 |
chr19_+_16222439 | 0.70 |
ENST00000300935.3
|
RAB8A
|
RAB8A, member RAS oncogene family |
chr4_+_48343339 | 0.70 |
ENST00000264313.6
|
SLAIN2
|
SLAIN motif family, member 2 |
chr1_+_155099927 | 0.69 |
ENST00000368407.3
|
EFNA1
|
ephrin-A1 |
chr1_+_90098606 | 0.68 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
chr1_+_154975110 | 0.68 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
chr12_+_65004292 | 0.68 |
ENST00000542104.1
ENST00000336061.2 |
RASSF3
|
Ras association (RalGDS/AF-6) domain family member 3 |
chr16_+_19125252 | 0.68 |
ENST00000566735.1
ENST00000381440.3 |
ITPRIPL2
|
inositol 1,4,5-trisphosphate receptor interacting protein-like 2 |
chr1_+_99127265 | 0.67 |
ENST00000306121.3
|
SNX7
|
sorting nexin 7 |
chr15_-_78369994 | 0.67 |
ENST00000300584.3
ENST00000409931.3 |
TBC1D2B
|
TBC1 domain family, member 2B |
chr3_+_152017181 | 0.67 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr10_-_15210666 | 0.67 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
chr2_-_69614373 | 0.66 |
ENST00000361060.5
ENST00000357308.4 |
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1 |
chr5_-_32174369 | 0.66 |
ENST00000265070.6
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein) |
chr8_-_99837856 | 0.66 |
ENST00000518165.1
ENST00000419617.2 |
STK3
|
serine/threonine kinase 3 |
chr9_-_14314066 | 0.66 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr21_-_37838739 | 0.65 |
ENST00000399139.1
|
CLDN14
|
claudin 14 |
chr16_-_70472946 | 0.65 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr8_-_71519889 | 0.65 |
ENST00000521425.1
|
TRAM1
|
translocation associated membrane protein 1 |
chr17_-_61920280 | 0.65 |
ENST00000448276.2
ENST00000577990.1 |
SMARCD2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
chr17_-_47841485 | 0.64 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr12_+_19592602 | 0.64 |
ENST00000398864.3
ENST00000266508.9 |
AEBP2
|
AE binding protein 2 |
chr20_-_36793774 | 0.64 |
ENST00000361475.2
|
TGM2
|
transglutaminase 2 |
chr12_+_122516626 | 0.64 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr3_+_191046810 | 0.63 |
ENST00000392455.3
ENST00000392456.3 |
CCDC50
|
coiled-coil domain containing 50 |
chr21_-_43346790 | 0.63 |
ENST00000329623.7
|
C2CD2
|
C2 calcium-dependent domain containing 2 |
chr11_+_111807863 | 0.63 |
ENST00000440460.2
|
DIXDC1
|
DIX domain containing 1 |
chr14_+_63671105 | 0.62 |
ENST00000316754.3
|
RHOJ
|
ras homolog family member J |
chr8_+_37654424 | 0.62 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
chr6_+_36164487 | 0.62 |
ENST00000357641.6
|
BRPF3
|
bromodomain and PHD finger containing, 3 |
chr10_-_52645416 | 0.61 |
ENST00000374001.2
ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF
|
APOBEC1 complementation factor |
chr5_-_77590480 | 0.61 |
ENST00000519295.1
ENST00000255194.6 |
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit |
chr6_+_160390102 | 0.61 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr11_+_120894781 | 0.61 |
ENST00000529397.1
ENST00000528512.1 ENST00000422003.2 |
TBCEL
|
tubulin folding cofactor E-like |
chr1_-_108507631 | 0.61 |
ENST00000527011.1
ENST00000370056.4 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr5_-_131563501 | 0.60 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr2_+_203499901 | 0.60 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
chrX_-_109561294 | 0.60 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr2_+_26915584 | 0.59 |
ENST00000302909.3
|
KCNK3
|
potassium channel, subfamily K, member 3 |
chr8_-_122653630 | 0.59 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr21_+_35445827 | 0.59 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr7_-_27219632 | 0.59 |
ENST00000470747.4
|
RP1-170O19.20
|
Uncharacterized protein |
chr1_+_21835858 | 0.59 |
ENST00000539907.1
ENST00000540617.1 ENST00000374840.3 |
ALPL
|
alkaline phosphatase, liver/bone/kidney |
chr13_+_26828275 | 0.59 |
ENST00000381527.3
|
CDK8
|
cyclin-dependent kinase 8 |
chr4_-_78740511 | 0.58 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr11_+_101981169 | 0.58 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
chr6_+_116601265 | 0.58 |
ENST00000452085.3
|
DSE
|
dermatan sulfate epimerase |
chr20_+_35974532 | 0.57 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr12_-_56224546 | 0.57 |
ENST00000357606.3
ENST00000547445.1 |
DNAJC14
|
DnaJ (Hsp40) homolog, subfamily C, member 14 |
chr1_+_206858232 | 0.56 |
ENST00000294981.4
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr17_+_61699766 | 0.56 |
ENST00000579585.1
ENST00000584573.1 ENST00000361733.3 ENST00000361357.3 |
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3 |
chr3_+_171758344 | 0.56 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr7_-_155604967 | 0.55 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
chr3_-_64673289 | 0.55 |
ENST00000295903.4
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
chr9_+_4490394 | 0.55 |
ENST00000262352.3
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
chr14_+_50359773 | 0.55 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr12_-_89919965 | 0.55 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr16_-_71323271 | 0.55 |
ENST00000565850.1
ENST00000568910.1 ENST00000434935.2 ENST00000338099.5 |
CMTR2
|
cap methyltransferase 2 |
chr11_-_61684962 | 0.55 |
ENST00000394836.2
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr4_+_159690218 | 0.54 |
ENST00000264433.6
|
FNIP2
|
folliculin interacting protein 2 |
chr10_+_75757863 | 0.54 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
chr1_+_61547894 | 0.54 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr14_-_74485960 | 0.54 |
ENST00000556242.1
ENST00000334696.6 |
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr22_+_21771656 | 0.53 |
ENST00000407464.2
|
HIC2
|
hypermethylated in cancer 2 |
chr2_+_235860616 | 0.53 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
chr4_-_135122903 | 0.53 |
ENST00000421491.3
ENST00000529122.2 |
PABPC4L
|
poly(A) binding protein, cytoplasmic 4-like |
chr7_-_41742697 | 0.53 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr13_-_76056250 | 0.53 |
ENST00000377636.3
ENST00000431480.2 ENST00000377625.2 ENST00000425511.1 |
TBC1D4
|
TBC1 domain family, member 4 |
chr6_-_107436473 | 0.52 |
ENST00000369042.1
|
BEND3
|
BEN domain containing 3 |
chr16_+_69221028 | 0.52 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr13_+_73632897 | 0.51 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr14_-_24658053 | 0.51 |
ENST00000354464.6
|
IPO4
|
importin 4 |
chr10_+_119000604 | 0.51 |
ENST00000298472.5
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2 |
chr12_-_14721283 | 0.51 |
ENST00000240617.5
|
PLBD1
|
phospholipase B domain containing 1 |
chr4_+_15004165 | 0.51 |
ENST00000538197.1
ENST00000541112.1 ENST00000442003.2 |
CPEB2
|
cytoplasmic polyadenylation element binding protein 2 |
chr15_+_81293254 | 0.51 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chr3_-_74570291 | 0.50 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
chr6_-_8435706 | 0.50 |
ENST00000379660.4
|
SLC35B3
|
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 |
chr11_-_8680383 | 0.50 |
ENST00000299550.6
|
TRIM66
|
tripartite motif containing 66 |
chr17_+_37026106 | 0.50 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
chr4_+_108745711 | 0.50 |
ENST00000394684.4
|
SGMS2
|
sphingomyelin synthase 2 |
chr16_-_84150492 | 0.49 |
ENST00000343411.3
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1 |
chrX_+_109246285 | 0.49 |
ENST00000372073.1
ENST00000372068.2 ENST00000288381.4 |
TMEM164
|
transmembrane protein 164 |
chr2_+_36582857 | 0.49 |
ENST00000280527.2
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
chr15_+_40763150 | 0.48 |
ENST00000306243.5
ENST00000559991.1 |
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 |
chr2_-_40679186 | 0.48 |
ENST00000406785.2
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr1_+_37940153 | 0.48 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr11_+_57435219 | 0.48 |
ENST00000527985.1
ENST00000287169.3 |
ZDHHC5
|
zinc finger, DHHC-type containing 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.6 | 1.7 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.5 | 1.9 | GO:0044691 | tooth eruption(GO:0044691) |
0.4 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 2.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 2.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 1.5 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.4 | 1.1 | GO:2000974 | auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
0.4 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.4 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 1.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) activation of protein kinase C activity(GO:1990051) |
0.3 | 1.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.3 | 1.0 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 1.0 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 1.5 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.3 | 0.9 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.3 | 0.9 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 0.7 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.2 | 1.9 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.2 | 1.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.2 | 0.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.2 | 0.8 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 1.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 1.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 0.5 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.2 | 1.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.2 | 1.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.1 | 1.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 1.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.8 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 1.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 1.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 1.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 1.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 2.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 2.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 0.3 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.2 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.1 | 0.4 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.3 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.1 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.3 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.1 | 0.7 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.3 | GO:1903984 | negative regulation of ribosome biogenesis(GO:0090071) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 1.4 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.3 | GO:0048936 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.1 | 0.4 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 0.4 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 0.4 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.1 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.1 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 1.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 1.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 2.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.4 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 1.2 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.1 | 0.6 | GO:0070777 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 1.0 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 0.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.8 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 1.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 1.0 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.4 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.0 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 1.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.3 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 1.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.6 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 1.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.0 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.4 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.8 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.0 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.5 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 1.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.3 | GO:1904179 | osteoblast fate commitment(GO:0002051) positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.1 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.0 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.0 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.3 | GO:0060413 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) atrial septum morphogenesis(GO:0060413) |
0.0 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.1 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.0 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.5 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.0 | 0.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 1.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 1.0 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.0 | 0.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 3.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 2.5 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.5 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 1.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.2 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 0.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.7 | GO:0044215 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 1.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 3.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 3.8 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 3.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 2.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 4.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.7 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 6.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.6 | 1.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.4 | 2.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 1.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.4 | 1.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.4 | 1.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 0.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.9 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.2 | 0.7 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.2 | 0.6 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.2 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 1.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 1.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 0.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.0 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.8 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.1 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.1 | 1.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.6 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.3 | GO:0010736 | serum response element binding(GO:0010736) |
0.1 | 0.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 1.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) copper-dependent protein binding(GO:0032767) |
0.0 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.0 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 3.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 1.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.0 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 3.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 1.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 0.4 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 1.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.6 | GO:0044548 | potassium ion leak channel activity(GO:0022841) S100 protein binding(GO:0044548) |
0.0 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 1.7 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.4 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 1.3 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 4.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 3.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 2.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 4.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 2.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 1.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 3.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |